Composition, form of production and packaging
Tablets from light brown to brown with lighter and darker patches, round, flat-cylindrical, with a bevel.
1 tab.
extract of rhizomes with roots of Nippon dioscorea (dry extract with the content of the sum of furostanol aglycones in terms of diosgenin and absolutely dry substance 1%) 100 mg
Excipients: lactose monohydrate 17 mg, potato starch 13 mg, magnesium oxide 7 mg, calcium stearate 3 mg.
10 pieces. - packings cellular planimetric (2) - packs cardboard.
10 pieces. - packings cellular planimetric (3) - packs cardboard.
10 pieces. - packings cellular planimetric (5) - packs cardboard.
INSTRUCTION FOR THE SPECIALIST.
Description of the drug approved by the manufacturer for the printed edition of 2013.
PHARMACHOLOGIC EFFECT
Reduces cholesterol, increases the phospholipids in the blood and lowers the cholesterol / phospholipid coefficient; lowers blood pressure.
INDICATIONS
- hypercholesterolemia (mild and moderate);
- Atherosclerosis of cerebral vessels both in its initial stages (for the prevention) and in severe forms of the disease; atherosclerosis of the heart vessels and the combination of atherosclerosis with hypertensive disease (as part of complex therapy).
DOSING MODE
Inside. 1-2 tablets 2-3 times a day after meals. Treatment is carried out in cycles of 20-30 days with 7-10-day intervals. The course of treatment is 3-4 months.
SIDE EFFECT
Possible allergic reactions (skin itching), decreased appetite, increased sweating.
If any of the side effects listed in the manual are aggravated, or if you notice any other side effects not listed in the instructions, tell your doctor.
CONTRAINDICATIONS
- deficiency of lactase;
lactose intolerance;
- glucose-galactose malabsorption;
- age up to 18 years;
- Hypersensitivity to the components of the drug.
With caution: arterial hypotension.
PREGNANCY AND LACTATION
It is not recommended for use during pregnancy and during breastfeeding because of the lack of specific safety data for this category of patients.
APPLICATION FOR CHILDREN
Contraindicated in children under 18 years.
SPECIAL INSTRUCTIONS
Impact on the ability to drive vehicles and manage mechanisms
The use of the drug does not affect the performance of potentially hazardous activities requiring special attention and quick reactions (vehicle management, working with moving mechanisms, dispatcher and operator work, etc.).
OVERDOSE
In case of an overdose, dose-dependent side effects may be increased.
DRUG INTERACTION
Not installed.
TERMS OF RELEASE FROM PHARMACY
Without recipe.
TERMS AND CONDITIONS OF STORAGE
In a dry, protected from light place at a temperature of no higher than 25 В° C. Keep out of the reach of children. Shelf life - 2 years.